Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study

被引:29
|
作者
Shea, Christopher M. [1 ]
Gertner, Alex K. [1 ]
Green, Sherri L. [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27599 USA
关键词
Primary health care; medication assisted treatment; opioid use disorder; ECHO; implementation barriers; PROJECT ECHO; SPECIALISTS; ADDICTION; CAPACITY; CARE;
D O I
10.1080/08897077.2019.1694617
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Medication treatment for opioid use disorder (M-OUD) is underutilized, despite research demonstrating its effectiveness in treating opioid use disorder (OUD). The UNC Extension for Community Healthcare Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) project was designed to evaluate interventions for reducing barriers to delivery of M-OUD by rural primary care providers in North Carolina. A key element was tele-conferenced sessions based on the University of New Mexico Project ECHO model, comprised of case discussions and didactic presentations using a "hub and spoke" model, with expert team members at the hub site and community-based providers participating from their offices (i.e., spoke sites). Although federal funders have promoted use of the model, barriers for providers to participate in ECHO sessions are not well documented. Methods: UNC ECHO for MAT included ECHO sessions, provider-to-provider consultations, and practice coaching. We conducted 20 semi-structured interviews to assess perceived usefulness of the UNC ECHO for MAT intervention, barriers to participation in the intervention, and persistent barriers to prescribing M-OUD. Results: Participants were generally satisfied with ECHO sessions and provider-to-provider consultations; however, perceived value of practice support was less clear. Primary barriers to participating in ECHO sessions were timing and length of sessions. Participants recommended recording ECHO sessions for viewing later, and some thought incentives for either the practice or provider could facilitate participation. Providers who had participated in ECHO sessions valued the expertise on the expert team; the team's ability to develop a supportive, collegial environment; and the value of a community of providers interested in learning from each other, particularly through case discussions. Conclusions: Despite the perceived value of ECHO, barriers may prevent consistent participation. Also, barriers to M-OUD delivery remain, including some that ECHO alone cannot address, such as Medicaid and private-insurer policies and availability of psychosocial resources.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [41] Increasing Office-Based Buprenorphine Availability and Efficacy through Coordination with Opioid Treatment Programs
    Stoller, Kenneth
    Louie, Christopher
    Stephens, Mary Ann
    AMERICAN JOURNAL ON ADDICTIONS, 2016, 25 (04): : 336 - 336
  • [42] Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality An Audit Study
    Beetham, Tamara
    Saloner, Brendan
    Wakeman, Sarah E.
    Gaye, Marema
    Barnett, Michael L.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (01) : 1 - +
  • [43] Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage
    Calcaterra, Susan L. L.
    Lockhart, Steven
    Natvig, Crystal
    Mikulich, Susan
    JOURNAL OF HOSPITAL MEDICINE, 2023, 18 (10) : 896 - 907
  • [44] Barriers and Facilitators to Expanding Buprenorphine Treatment for Opioid Use Disorder in Jail Settings
    Kelsch, Jordan
    McGladrey, Margaret
    Oser, Carrie
    Booty, Marisa
    Fanucchi, Laura
    Walsh, Sharon
    Lofwall, Michelle
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [45] Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders
    Carey, Katelyn J.
    Huang, Wei
    Linas, Benjamin P.
    Tsui, Judith I.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2016, 66 : 54 - 59
  • [46] Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients
    Brent A. Moore
    David A. Fiellin
    Declan T. Barry
    Lynn E. Sullivan
    Marek C. Chawarski
    Patrick G. O’Connor
    Richard S. Schottenfeld
    Journal of General Internal Medicine, 2007, 22 : 527 - 530
  • [47] Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients
    Moore, Brent A.
    Fiellin, David A.
    Barry, Declan T.
    Sullivan, Lynn E.
    Chawarski, Marek C.
    O'Connor, Patrick G.
    Schottenfeld, Richard S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (04) : 527 - 530
  • [48] Undergraduate-Level Health Coaches as Volunteers to Assist with Office-Based Opioid Treatment with Buprenorphine
    Gonzalez, Kellie Foxx
    Meyers, Sarah
    Portelli-Gupta, Jen
    Valentine, Alexander
    Brick, David
    Matthews, Michelle
    Suzuki, Joji
    AMERICAN JOURNAL ON ADDICTIONS, 2017, 26 (03): : 285 - 286
  • [49] Office-Based Buprenorphine Treatment Identifying Factors That Promote Retention in Opioid-Dependent Patients
    Noe, Shelly R.
    Keller, Teresa
    JOURNAL OF ADDICTIONS NURSING, 2020, 31 (01) : 23 - 29
  • [50] Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study
    Barry, Declan T.
    Savant, Jonathan D.
    Beitel, Mark
    Cutter, Christopher J.
    Moore, Brent A.
    Schottenfeld, Richard S.
    Fiellin, David A.
    AMERICAN JOURNAL ON ADDICTIONS, 2013, 22 (03): : 212 - 217